(ISSN 2577-5820)
OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
The journal publishes all types of articles in English. There is no restriction on the length of the papers. We encourage authors to be concise but present their results in as much detail as necessary, as reviewers are expected to emphasize scientific rigor and reproducibility.
Publication Speed (median values for papers published in 2023): Submission to First Decision: 6.7 weeks; Submission to Acceptance: 14.4 weeks; Acceptance to Publication: 6 days (1-2 days of FREE language polishing included)
Special Issue
Complications of Bone Marrow Transplantation
Submission Deadline: February 15, 2026 (Open) Submit Now
Guest Editor
Anastasiia V. Bondarenko, MD, PhD
Professor, Head of the Department of Pediatrics, Immunology, Infectious and Rare Diseases, European Medical School, International European University, Kyiv, Ukraine
Research Interests: Inborn errors of immunity (diagnostics and treatment); immune reconstitution after bone marrow transplantation; interaction of infections and immunity; immunoprophylaxis of infectious diseases
About This Topic
Hematopoietic stem cell transplantation (HSCT) is becoming increasingly promising as a radical treatment for a wide range of diseases such as leukemia, lymphoma, aplastic anemia, inborn errors of immunity, metabolic diseases, etc. While it can be life-saving, it carries several risks and complications, both during the transplant process and in the long term. In recent decades, significant progress has been made in patient survival. The risks and complications of bone marrow transplantation (BMT) vary depending on the patient’s age, the underlying condition, the donor type (matched sibling, unrelated donor, or autologous transplant), and the specific treatment regimen used. In order to improve the results of HSCT and predict the occurrence of complications, it is very important to share experiences, features, and evaluation of bone marrow transplantation results in different centers and worldwide.
We invite you to share your experience by submitting publications on the results of your BMT center, as well as cohort studies and literature reviews. Publications may relate to but are not limited to graft-versus-host disease, infections, rejection of the graft, organ toxicity, engraftment syndrome, secondary cancers, osteoporosis, endocrine complications, graft failure), psychosocial issues, and management of complications.
Keywords
Hematopoietic stem cell transplantation; bone marrow transplantation; complications; graft-versus-host disease; infections; graft failure
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (transplantation@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
- Journal Metrics
-
2023 
CiteScore SJR SNIP 0.6 0.179 0.17 - Newsletter